| Danielle H Martini, | |
|
2341 Mccallie Ave, Suite 402, Chattanooga, TN 37404-3239 | |
| (423) 698-3309 | |
| (423) 624-6355 |
| Full Name | Danielle H Martini |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 14 Years |
| Location | 2341 Mccallie Ave, Chattanooga, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154637270 | NPI | - | NPPES |
| 4273603 | Other | TN | BLUE CROSS BLUE SHIELD OF TN |
| 1520978 | Medicaid | TN | |
| P00876903 | Other | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 153716 (Tennessee) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | APN15158 (Tennessee) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Crna Associates, P.c. | 8820980212 | 15 |
News Archive
Novartis announced today that the European Commission has approved Cosentyx (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and psoriatic arthritis (PsA). For AS, this is the first new treatment advance in 16 years since the development of the current standard of care, anti-tumor necrosis factor (anti-TNF) therapy.
Over the last several decades, the prophylactic use of acid-suppressive medications to help prevent gastrointestinal bleeding in hospitalized patients has increased significantly, with some studies estimating that as many as 40 to 70 percent of all medical inpatients are given these drugs at some point during their hospitalization.
In what the authors believe is the first documented comparison of several real-time infectious disease forecasting models by different teams across many seasons, five research groups report this week that a majority of models consistently showed higher accuracy than historical baseline models.
A study of home health care nurses in the United States has found that attitudes and organizational policies, rather than knowledge base was much more likely to lead to greater compliance with infection control.
Researchers at the University of Alabama at Birmingham have identified a chemical pathway that may be associated with seizures and shorter patient survival in some patients with malignant glioma, the most common and deadly form of brain tumor. In findings published May 27 in Science Translational Medicine, the researchers suggest that a transporter known as SXC is responsible for boosting levels of glutamate in the brains of some glioma patients.
› Verified 8 days ago
| Entity Name | Crna Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942233150 PECOS PAC ID: 8820980212 Enrollment ID: O20040329001515 |
News Archive
Novartis announced today that the European Commission has approved Cosentyx (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and psoriatic arthritis (PsA). For AS, this is the first new treatment advance in 16 years since the development of the current standard of care, anti-tumor necrosis factor (anti-TNF) therapy.
Over the last several decades, the prophylactic use of acid-suppressive medications to help prevent gastrointestinal bleeding in hospitalized patients has increased significantly, with some studies estimating that as many as 40 to 70 percent of all medical inpatients are given these drugs at some point during their hospitalization.
In what the authors believe is the first documented comparison of several real-time infectious disease forecasting models by different teams across many seasons, five research groups report this week that a majority of models consistently showed higher accuracy than historical baseline models.
A study of home health care nurses in the United States has found that attitudes and organizational policies, rather than knowledge base was much more likely to lead to greater compliance with infection control.
Researchers at the University of Alabama at Birmingham have identified a chemical pathway that may be associated with seizures and shorter patient survival in some patients with malignant glioma, the most common and deadly form of brain tumor. In findings published May 27 in Science Translational Medicine, the researchers suggest that a transporter known as SXC is responsible for boosting levels of glutamate in the brains of some glioma patients.
› Verified 8 days ago
| Entity Name | American Anesthesiology Of Tennessee Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609822998 PECOS PAC ID: 9931001922 Enrollment ID: O20040713001364 |
News Archive
Novartis announced today that the European Commission has approved Cosentyx (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and psoriatic arthritis (PsA). For AS, this is the first new treatment advance in 16 years since the development of the current standard of care, anti-tumor necrosis factor (anti-TNF) therapy.
Over the last several decades, the prophylactic use of acid-suppressive medications to help prevent gastrointestinal bleeding in hospitalized patients has increased significantly, with some studies estimating that as many as 40 to 70 percent of all medical inpatients are given these drugs at some point during their hospitalization.
In what the authors believe is the first documented comparison of several real-time infectious disease forecasting models by different teams across many seasons, five research groups report this week that a majority of models consistently showed higher accuracy than historical baseline models.
A study of home health care nurses in the United States has found that attitudes and organizational policies, rather than knowledge base was much more likely to lead to greater compliance with infection control.
Researchers at the University of Alabama at Birmingham have identified a chemical pathway that may be associated with seizures and shorter patient survival in some patients with malignant glioma, the most common and deadly form of brain tumor. In findings published May 27 in Science Translational Medicine, the researchers suggest that a transporter known as SXC is responsible for boosting levels of glutamate in the brains of some glioma patients.
› Verified 8 days ago
| Entity Name | Physicians Surgery Center Of Chattanooga Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164589032 PECOS PAC ID: 8527072115 Enrollment ID: O20060202000955 |
News Archive
Novartis announced today that the European Commission has approved Cosentyx (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and psoriatic arthritis (PsA). For AS, this is the first new treatment advance in 16 years since the development of the current standard of care, anti-tumor necrosis factor (anti-TNF) therapy.
Over the last several decades, the prophylactic use of acid-suppressive medications to help prevent gastrointestinal bleeding in hospitalized patients has increased significantly, with some studies estimating that as many as 40 to 70 percent of all medical inpatients are given these drugs at some point during their hospitalization.
In what the authors believe is the first documented comparison of several real-time infectious disease forecasting models by different teams across many seasons, five research groups report this week that a majority of models consistently showed higher accuracy than historical baseline models.
A study of home health care nurses in the United States has found that attitudes and organizational policies, rather than knowledge base was much more likely to lead to greater compliance with infection control.
Researchers at the University of Alabama at Birmingham have identified a chemical pathway that may be associated with seizures and shorter patient survival in some patients with malignant glioma, the most common and deadly form of brain tumor. In findings published May 27 in Science Translational Medicine, the researchers suggest that a transporter known as SXC is responsible for boosting levels of glutamate in the brains of some glioma patients.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Danielle H Martini, Po Box 3549, Chattanooga, TN 37404-0549 Ph: (423) 698-3309 | Danielle H Martini, 2341 Mccallie Ave, Suite 402, Chattanooga, TN 37404-3239 Ph: (423) 698-3309 |
News Archive
Novartis announced today that the European Commission has approved Cosentyx (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and psoriatic arthritis (PsA). For AS, this is the first new treatment advance in 16 years since the development of the current standard of care, anti-tumor necrosis factor (anti-TNF) therapy.
Over the last several decades, the prophylactic use of acid-suppressive medications to help prevent gastrointestinal bleeding in hospitalized patients has increased significantly, with some studies estimating that as many as 40 to 70 percent of all medical inpatients are given these drugs at some point during their hospitalization.
In what the authors believe is the first documented comparison of several real-time infectious disease forecasting models by different teams across many seasons, five research groups report this week that a majority of models consistently showed higher accuracy than historical baseline models.
A study of home health care nurses in the United States has found that attitudes and organizational policies, rather than knowledge base was much more likely to lead to greater compliance with infection control.
Researchers at the University of Alabama at Birmingham have identified a chemical pathway that may be associated with seizures and shorter patient survival in some patients with malignant glioma, the most common and deadly form of brain tumor. In findings published May 27 in Science Translational Medicine, the researchers suggest that a transporter known as SXC is responsible for boosting levels of glutamate in the brains of some glioma patients.
› Verified 8 days ago
Megan A Spears, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-602-8400 Fax: 423-602-8401 | |
Mr. Edward Brian Hallock, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-602-8400 Fax: 423-602-8401 | |
Amy T. Garner, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2341 Mccallie Ave, Suite 402, Chattanooga, TN 37404 Phone: 423-698-3309 Fax: 423-624-6355 | |
Eun Hyea Godbold, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2525 Desales Ave, Chattanooga, TN 37404 Phone: 423-495-2525 | |
Christina Michelle Robinson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 979 E 3rd St Ste C235, Chattanooga, TN 37403 Phone: 423-602-8400 | |
Mrs. Julie D Baggett, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2341 Mccallie Ave, Suite 402, Chattanooga, TN 37404 Phone: 423-698-3309 Fax: 423-624-6355 | |
Susan L Battles, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 975 E Third St, Chattanooga, TN 37403 Phone: 423-778-7608 Fax: 423-778-2360 |